The effect of cyclosporine vs FK 506 on glucose metabolism

By Steinmueller T.   Konrad T.   Jonas S.   Tullius S.   Bechstein W.O.   Mueller A.   Platz K.P.   Neumann U.   Vicini P.   Toffolo G.   Cobelli C.   Usadel K.H.   Neuhaus P.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1129-1130

Elsevier

Access to resources Recommend Favorite

Intestinal metabolism of cyclosporine a in human heart transplant recipients

By Lehle K.   Kirchner G.   Sewing K.F.   Rupprecht L.   Merk J.   Preuner J.G.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4044-4044

Elsevier

Access to resources Recommend Favorite

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)

By Kramer M.R.   Merin G.   Rudis E.   Bar I.   Nesher T.   Bublil M.   Milgalter E.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2657-2659

Elsevier

Access to resources Recommend Favorite

Clinical trial of FK506 in heart transplant patients in taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506

By Ko W.J.   Chou N.K.   Chen Y.S.   Hsu R.B.   Wang S.S.   Chu S.H.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3339-3341

Elsevier

Access to resources Recommend Favorite

Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients

By Vela C.G.   Cristol J.P.   Descomps B.   Mourad G.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 398-398

Elsevier

Access to resources Recommend Favorite